Immediate vs. Delayed Stenting in Primary PCI

Original Title: Comparison of Immediate With Delayed Stenting Using the Minimalist Immediate Mechanical Intervention Approach in Acute ST-Segment–Elevation Myocardial Infarction. The MIMI Study. Reference: Loic Belle et al. Circ Cardiovasc Interv. 2016 Mar;9(3).

 

Delayed stenting after normal epicardial flow restoration is meant to lower the chance of distal embolization and to improve reperfusion in the context of primary PCI.

This study was designed to compare the minimalist technique of delayed stenting (a las 24-48 hs) vs. immediate stenting in patients undergoing ST elevation MI, receiving primary PCI.

It included 140 patients undergoing ≤12 hr. evolution STEMI randomized to immediate stenting (n=73) vs delayed stenting (n=67) after TIMI flow III restoration by thromboaspiration.

Patients in the delayed stenting group had a second stenting procedure at mean 36 hrs. after randomization (range 29-46 hrs.).

Primary end point was micro vascular obstruction by MRI at 5 days after the first procedure.

A minor tendency to less micro vascular obstruction in the immediate stent group was observed, compared to the delayed stent group (1.88% vs 3.96%; p=0.051); this difference became significant after adjusting for area at risk (p=0.049).

Mean infarction size and ejection fraction resulted similar between the groups.

There were no differences in cardiovascular events after 6 months.

Conclusion
The result of this study does not support the delayed stenting strategy in patients undergoing primary PCI and even suggests it could be detrimental.

More articles by this author

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions

Coronary calcification is associated with stent under-expansion and increased risk of both early and late adverse events. Atherectomy is an essential tool for uncrossable...

TCT 2024 | Use of Drug-Coated Balloons for Side Branch Treatment in Provisional Stenting

In some cases, treating coronary bifurcations with provisional stenting requires side branch stenting, which may lead to suboptimal outcomes. Drug-coated balloons (DCBs) have emerged...

TCT 2024 | Use of Artificial Intelligence for Patients with Suspected Coronary Artery Disease

The current approach to chest pain mainly focuses on symptom characteristics, conducting functional tests for ischemia assessment. However, several randomized clinical trials have shown...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...